LD3

Leicester Drug Discovery and Diagnostics supports translational research within the College of Life Sciences, providing pump-prime funding opportunities from sequential UKRI - Impact Acceleration Accounts (IAAs) to researchers to accelerate the development of medicines, therapies, diagnostic tests and devices with ‘real world benefit’ for patients.